Evidence map›Paper›PMID 38057652›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

Performance of [

Aymeric Boucher, Julia Delabie, Charlotte Lussey-Lepoutre, Magalie Haissaguerre, Eric Ouvrard, Vija Lavinia, Maëlle Le Bras, Marie Batisse-Lignier, Thomas Cuny, Nicolas Jacquet-Francillon and 12 more

Open access · greenAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Expanding the clinical indications of [European journal of nuclear medicine and molecular imaging · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Aymeric BoucherDepartment of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, 264 Rue Saint-Pierre, 13385, Marseille, France.
Julia DelabieDepartment of Endocrinology, Hôpital Louis Pradel, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Charlotte Lussey-LepoutreDepartment of nuclear medicine, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.
Magalie HaissaguerreDepartment of Endocrinology and Endocrine Oncology, Haut Leveque Hospital, University Hospital of Bordeaux, Pessac, France.
Eric OuvrardDepartment of Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.
Vija LaviniaDepartment of Nuclear Medicine, Oncopole Claudius Regaud, Toulouse, France.
Maëlle Le BrasDepartment of Endocrinology, Diabetology and Nutrition, L'institut du Thorax, CHU Nantes, 44000, Nantes, France.
Marie Batisse-LignierDepartment of Nuclear Medicine, Centre Jean Perrin, Clermont-Ferrand, France.
Thomas CunyDepartment of Endocrinology, Conception Hospital, Aix-Marseille University, Marseille, France.
Nicolas Jacquet-FrancillonDepartment of Nuclear Medicine, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, Lyon Sud Hospital, Pierre-Bénite, Lyon, France.
Sébastien GaujouxDepartment of General, Visceral, and Endocrine Surgery, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne Université, Paris, France.
Océane MolinaDepartment of Endocrinology and Endocrine Oncology, Haut Leveque Hospital, University Hospital of Bordeaux, Pessac, France.
Alessio ImperialeDepartment of Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.
Adrien LatgeDepartment of Nuclear Medicine, Oncopole Claudius Regaud, Toulouse, France.
Catherine AnsquerDepartment of Nuclear Medicine, CHU Nantes, Nantes Université, 44000, Nantes, France.
Antony KellyDepartment of Nuclear Medicine, Centre Jean Perrin, Clermont-Ferrand, France.
Françoise Borson-ChazotDepartment of Endocrinology, Hôpital Louis Pradel, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France.
Ghoufrane TliliDepartment of Nuclear Medicine, Bordeaux University and Hospitals, 33604, Bordeaux, France.
Frédéric SebagDepartment of Endocrine Surgery, Aix-Marseille University, Conception Hospital, Marseille, France.
Zeinab HamidouDepartment of Public Health, Aix-Marseille University, Marseille, France.
Pauline RomanetLaboratory of Molecular Biology Hospital La Timone, Aix Marseille Univ, APHM, INSERM, MMG, Marseille, France.
David TaïebDepartment of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, 264 Rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.ORCID 0000-0002-0400-7600
Aix-Marseille Université · FRUniversité Claude Bernard Lyon 1 · FRCentre Jean Perrin · FRHôpital Cardiologique du Haut-Lévêque · FRInstitut Claudius Regaud · FRInstitut de Cancérologie Strasbourg · FRSorbonne Université · FRInserm · FRInstitut du Thorax · FRNantes Université · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aims of the study were to evaluate the performance and robustness of [

methodsRetrospective French multicenter study including patients with MEN1 pHPT who underwent [

resultsA total of 71 MEN1 patients were included (73 PET/CT) in the study. At the per-patient level (entire cohort), [

conclusion[

Indexed as

Hyperparathyroidism, PrimaryPositron Emission Tomography Computed TomographyCholineHumansParathyroid GlandsReproducibility of ResultsRetrospective StudiesCholinefluorocholinefluoromethylcholine[18F]fluorocholineGeneticsMEN1Neuroendocrine tumorsPositron emission tomography

Identifiers

PMID38057652
OpenAlexW4389410339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.